“`html
The average one-year price target for Molecular Partners AG – Depositary Receipt (NasdaqGS:MOLN) has been raised to $15.45 per share, an 11.97% increase from the previous estimate of $13.80 on October 29, 2025. This updated target reflects a potential upside of 241.14% from the latest closing price of $4.53 per share. The range of price targets from analysts varies from a low of $8.74 to a high of $22.73 per share.
Institutional holdings in Molecular Partners AG have decreased by one owner (11.11%) in the last quarter, with eight funds currently reporting positions. The average portfolio weight in MOLN among these funds has increased by 18.98%, totaling 3,587K shares owned, reflecting a marginal increase of 0.10% over the past three months. Notably, UBS Group increased its shares held from 6K to 10K, a rise of 37.73% within the same period.
“`
